Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
1.1Branched chains for hydrophobic association
What ifWhat if the aliphatic side chain uses regularly spaced methyl branches so that it contains at most two consecutive methylene groups?
Claim language“with at least four consecutive-CH2-groups”
The thiol group of 3,7-dimethyloctane-1-thiol adds across a pendant vinyl sulfone group to form a thioether. The branched ten-carbon chains associate in water and provide hydrophobic domains within the hydrated polymer assembly.
1.2One chain with two termini
What ifWhat if both pendant populations use the same twelve-carbon spacer and differ in their terminal groups?
Claim language“R1 and R2 are different from each other”
Dodecane-1-thiol and 12-mercaptododecanoic acid each add to pendant vinyl sulfone groups through sulfur. Both pendants share a twelve-methylene spacer, while their hydrogen and carboxyl termini give the two populations different polarity.
1.4Polyester core for hydrophobic cargo
What ifWhat if a biodegradable polyester forms the hydrophobic phase of the formulation?
Claim language“a lipid”
Nanoprecipitation of polycaprolactone from a water-miscible solvent forms solid particles that incorporate a hydrophobic cargo. Alkyl pendants on the hyaluronic acid derivative adsorb to the particle surface and present hydrated polysaccharide segments to the surrounding water.
Section 2 · machine-generated
Variations
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
Other field of use
Water retention in ceramic pastes
Hyaluronic acid bearing pendant C12 alkyl groups is hydrated in water and mixed with glyceryl monooleate to form a lipid dispersion. The dispersion is blended into an aqueous alumina paste before extrusion. The alkyl groups associate with the lipid domains, while the hydrated hyaluronic acid increases the viscosity of the water between the alumina particles.
Component substitution
Chondroitin sulfate as the polymer backbone
Chondroitin sulfate replaces hyaluronic acid as the polysaccharide backbone. Divinyl sulfone reacts with available backbone hydroxyl groups in alkaline water, and a C12 thiol adds to the pendant vinyl sulfone groups to form thioether-linked alkyl side chains. The purified polymer is dispersed with glyceryl monooleate in water, where its alkyl side chains associate with the lipid and its sulfated backbone remains hydrated.
Amide linkages for pendant alkyl groups
Amide linkages replace the sulfone-containing linkages that tether alkyl groups to the polymer. A water-soluble carbodiimide activates a fraction of the hyaluronic acid carboxyl groups, and dodecylamine in a water-miscible cosolvent reacts with the activated groups. Dialysis removes small molecules and cosolvent before the polymer is mixed with glyceryl monooleate in water. The pendant dodecyl groups associate with lipid domains while the remaining carboxylate groups maintain polymer hydration.
Parameter or scale variation
Millimeter scale lipid composite beads
An aqueous feed containing hyaluronic acid with C12 alkyl side chains and residual vinyl sulfone groups is mixed with dispersed glyceryl monooleate. A droplet generator meters 0.5 to 4 microliters of feed per droplet into a stirred oil bath, giving nominal droplet diameters of 1 to 2 millimeters. A water-soluble polyethylene glycol dithiol is mixed into the feed immediately upstream of the nozzle and reacts with the residual vinyl sulfone groups inside the droplets. The gelled beads are recovered and washed to remove the carrier oil.
Combination with existing systems
Crosslinked coating on a cellulose dressing
An aqueous dispersion of glyceryl monooleate and hyaluronic acid bearing C12 alkyl groups and residual vinyl sulfone groups is combined with a water-soluble dithiol. A roll coater deposits the mixture onto a porous cellulose dressing, where it penetrates the surface fiber layer before gelation. The dithiol crosslinks the polymer around the fibers, and the resulting coating takes up water through the exposed pores.
Automated or data-driven variant
Feedback control of dispersion particle size
Metering pumps feed an aqueous solution of C12-modified hyaluronic acid and an ethanolic solution of glyceryl monooleate into a static mixer. An automated sampler dilutes a side stream with the same aqueous medium for particle size measurement by dynamic light scattering. A controller compares the rolling mean particle diameter with a setpoint and adjusts total flow while maintaining the polymer-to-lipid feed ratio. The controller diverts output when readings fall outside the specified diameter band.
Specific version of a part
Azide groups for later coupling
A thiol bearing a terminal azide adds across the residual vinyl sulfone groups and installs pendant azides. The azides react with a polymer bearing strained cyclooctyne groups to form triazole crosslinks.
Dodecyl thioether pendants
Dodecane-1-thiol adds to vinyl sulfone groups attached through hyaluronic acid hydroxyl oxygens. Each resulting pendant contains a sulfone linker, a thioether, and a twelve-carbon chain with a hydrogen terminus.
Mixed octyl and hexadecyl pendants
Octane-1-thiol and hexadecane-1-thiol add to different pendant vinyl sulfone groups on the same hyaluronic acid chain. The resulting thioethers carry eight-carbon and sixteen-carbon hydrophobic groups, both with hydrogen termini.
Partial addition of dodecanethiol
A substoichiometric amount of dodecane-1-thiol reacts with pendant vinyl sulfone groups on a hyaluronic acid chain that carries multiple such groups. The derivative carries both dodecyl thioether pendants and unreacted vinyl sulfone sites for subsequent thiol coupling.
Phosphatidylcholine vesicle bilayer
Hydration of a dried phosphatidylcholine film produces vesicles, and extrusion through a porous membrane controls their size distribution. Hydrophobic pendants on the hyaluronic acid derivative associate with the bilayer while the hydrated polysaccharide extends into the aqueous phase.
Section 3 · quoted from USPTO records
Other work
Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.
1.1A) HA-(OCH2CH2SO2CH2CH2—X—R1—Y)n, where HA is hyaluronic acid, X is S or NH, R1 is a substituted or unsubstituted C8-C20 aliphatic with at least four consecutive-CH2-groups, a cholesterol moiety, or a lipid moiety, and Y is one or more of H, a carboxylic acid group or a salt or ester thereof, a hydroxyl group, a sulfonic acid group or a salt thereof, or an amine group, and n is the number of modified hydroxyl groups where n≥1; or
Amidic, water-soluble compounds according to claim 1, obtained by reaction of the carboxylic groups of hyaluronic acid with an amino group of the aliphatic, aromatic, arylaliphatic, cycloaliphatic, heterocyclic series.
A · US 2010/0158796 A1 · claim 2
a) the derivative of the polyhydric polymer, such as hyaluronic acid has the structure HA-(OCH2CH2SO2CH2CH2—X—R1—Y)n wherein one or more hydroxyl groups of the hyaluronic acid is a modified hydroxyl group, and wherein HA is the polyhydric polymer, e.g., hyaluronic acid, comprising hydroxyl groups, X is S or NH, R1 is a substituted or unsubstituted C1-C20 aliphatic or aromatic moiety and n is the number of modified hydroxyl groups where n≥1, and Y is H; a carboxylic acid group
B · US 2020/0190225 A1 · ¶ 14
1.2B) (Y—R2—X—CH2CH2SO2CH2CH2O)m-HA-(OCH2CH2SO2CH2CH2—X—R1—Y)n, where HA is hyaluronic acid, X is S or NH, R1 and R2 are each a substituted or unsubstituted C8-C20 aliphatic with at least four consecutive-CH2-groups, a cholesterol moiety, or a lipid moiety, wherein R1 and R2 are different from each other, Y may be the same or different, and Y is one or more of H, a carboxylic acid group or a salt or ester thereof, a hydroxyl group, a sulfonic acid group or a salt thereof, or an amine group, or an amine group, and n≥1 and m≥1; or
a) the derivative of a polyhydric polymer, comprises two or more hydroxyl groups of the hyaluronic acid as modified hydroxyl groups, wherein the derivative of hyaluronic acid or other polyhydric polymer has the structure (Y—R2—X—CH2CH2SO2CH2CH2O)m-HA-(OCH2CH2SO2CH2CH2—X—R1—Y)n where HA is hyaluronic acid or other polyhydric polymer, X is S or NH, R1 is a substituted or unsubstituted C1-C20 aliphatic or aromatic moiety, R2 is a substituted or unsubstituted C1-C20 aliphatic or
B · US 2020/0190225 A1 · ¶ 17
1.3C) (CH2═CH—SO2CH2CH2O)m-HA-(OCH2CH2SO2CH2CH2—X—R1—Y)n, where HA is hyaluronic acid, X is S or NH, R1 is a substituted or unsubstituted C8-C20 aliphatic with at least four consecutive-CH2-groups, a cholesterol moiety, or a lipid moiety, Y is one or more of H, a carboxylic acid group or a salt or ester thereof, a hydroxyl group, a sulfonic acid group or a salt thereof, or an amine group, and n≥1 and m≥1;
a) the derivative of hyaluronic acid comprises vinyl groups and has the structure (CH2═CH—SO2CH2CH2O)m-HA-(OCH2CH2SO2CH2CH2—X—R1—Y)n wherein two or more hydroxyl groups of the hyaluronic acid are modified hydroxyl groups, HA is hyaluronic acid comprising hydroxyl groups, X is S or NH, R1 is a substituted or unsubstituted C1-C20 aliphatic or aromatic moiety, n≥1 and m≥1, and Y is H; a carboxylic acid group, or a salt or ester; thereof; a hydroxyl group; a sulfonic acid group,
B · US 2020/0190225 A1 · ¶ 20
1.4and a lipid.
Phospholipids that can be used include but are not limited to hydrogenated soy phosphatidylcholine, distearoylphosphatidylglycerol, L-α-dimyristoylphosphatidylcholine, L-α-dimyristoylphosphatidylglycerol
B · US 2020/0190225 A1 · ¶ 232
An empty cell means only that no passage was reproduced there.
Statements in these documents
The present invention is directed to amides of hyaluronic acid and derivatives thereof for the preparation of pharmaceutical formulations, of biomaterials and for the coating of biomedical objects and the process for their preparation.
A · US 2010/0158796 A1 · ¶ 2
The purpose of these compounds is to focus the action of the active principle on the diseased tissues and to limit any harmful effects on the healthy tissues.
A · US 2010/0158796 A1 · ¶ 6
The polymers of the present disclosure provide useful properties that are not available from polymers currently available.
B · US 2020/0190225 A1 · ¶ 2
What is needed are derivatives of polyhydric polymers, compositions of such polymers and use of such polymers for medical treatments and production of medical devices and components.
B · US 2020/0190225 A1 · ¶ 6
Cite aspatent.fyi, US 2026/0355114 A1, claim 1, first published 2026-11-19T08:28:42-05:00, https://patent.fyi/US20260355114/, SHA-256 976873411b3c80e13f405c90f2f47afbcce243146713b07d1b7be3c83bf2b4b2